01 1Aurobindo Pharma Limited
02 2Chemeca Drugs Private Limited
03 1Harman Finochem Limited
04 1Olon SpA
05 1PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
06 1Professional Compounding Centers of America dba PCCA
07 1Siegfried Evionnaz SA
08 1UQUIFA MEXICO, S.A. DE C.V.
01 2CARISOPRODOL
02 6Carisoprodol
03 1carisoprodol
01 4India
02 1Italy
03 1Spain
04 1Switzerland
05 2United Kingdom
NDC Package Code : 65862-260
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 77777-112
Start Marketing Date : 2019-09-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 77777-112
Start Marketing Date : 2023-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 66064-5001
Start Marketing Date : 2008-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0406
Start Marketing Date : 2017-02-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0355
Start Marketing Date : 2025-02-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-3169
Start Marketing Date : 2011-12-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17381-080
Start Marketing Date : 2010-04-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52286-0021
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
79
PharmaCompass offers a list of Carisoprodol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carisoprodol manufacturer or Carisoprodol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carisoprodol manufacturer or Carisoprodol supplier.
PharmaCompass also assists you with knowing the Carisoprodol API Price utilized in the formulation of products. Carisoprodol API Price is not always fixed or binding as the Carisoprodol Price is obtained through a variety of data sources. The Carisoprodol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CARISOPRODOL [USP MONOGRAPH] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CARISOPRODOL [USP MONOGRAPH], including repackagers and relabelers. The FDA regulates CARISOPRODOL [USP MONOGRAPH] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CARISOPRODOL [USP MONOGRAPH] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CARISOPRODOL [USP MONOGRAPH] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CARISOPRODOL [USP MONOGRAPH] supplier is an individual or a company that provides CARISOPRODOL [USP MONOGRAPH] active pharmaceutical ingredient (API) or CARISOPRODOL [USP MONOGRAPH] finished formulations upon request. The CARISOPRODOL [USP MONOGRAPH] suppliers may include CARISOPRODOL [USP MONOGRAPH] API manufacturers, exporters, distributors and traders.
click here to find a list of CARISOPRODOL [USP MONOGRAPH] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CARISOPRODOL [USP MONOGRAPH] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CARISOPRODOL [USP MONOGRAPH] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CARISOPRODOL [USP MONOGRAPH] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CARISOPRODOL [USP MONOGRAPH] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CARISOPRODOL [USP MONOGRAPH] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CARISOPRODOL [USP MONOGRAPH] suppliers with NDC on PharmaCompass.
We have 7 companies offering CARISOPRODOL [USP MONOGRAPH]
Get in contact with the supplier of your choice:
